Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

ERC Starting Grant for Lena Maier-Hein

No. 66 | 17/12/2014 | by Koh

The European Research Council (ERC) awards “Starting Grants” to support excellent young scientists who are starting an independent science career. Lena Maier-Hein, a computer scientist from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg, has now received the prestigious grant for a multidisciplinary project: She plans to combine computer-navigated minimally invasive surgery with novel, gentle imaging technology based on sound and light. The additional imaging information will help physicians get a clearer picture of diseased tissue.

Lena Maier-Hein
© DKFZ/Tobias Schwerdt

Minimally invasive surgery is gaining increasing importance in the diagnosis and treatment of cancer and other diseases. When performing minimally invasive surgery, clinicians are faced with two major challenges: First, they need to differentiate between malignant tissue and healthy tissue, which can be difficult even in open surgery. If this differentiation cannot be reliably made, the tumor may recur or the surgery performed may be unnecessarily radical. Second, surgeons need to know precisely how to insert endoscopic instruments into a target region without injuring nearby organs.

Associate Professor (PD) Dr. Lena Maier-Hein addresses these challenges in a multidisciplinary project that is now supported by the European Research Council (ERC). Maier-Hein, a computer scientist, plans to use medical imaging methods based on light and sound signals for the first time to capture important tissue parameters (such as oxygen saturation in the blood) in real time and thus to provide physicians with additional information about tissue characteristics.

So far, physicians have gained special orientation inside the body using an endoscopic camera that uses white light to illuminate the target area. This type of illumination delivers only poor contrasts and little depth of vision, which makes it difficult to handle the instruments precisely. Lena Maier-Hein now plans to combine standard imaging with an emerging technology called multispectral optical and photoacoustic imaging. “This will enable us to visualize not only the three-dimensional surface of tissues, but additionally the details that are hidden beneath, such as the structure of blood vessels, blood supply and oxygen saturation in the target region,” Maier-Hein explains. “This provides physicians with important clues about potential malignant tissue alterations.”

An important component of the project is photoacoustic imaging, a technology that is capable of capturing structural and functional tissue parameters non-invasively and without exposure to radiation. Maier- Hein plans to use this technology in a multispectral mode in order to determine the molecular composition of tissues and to reconstruct important tumor markers such as changes in oxygen saturation or abnormal vessel microstructure.

During surgery, the surgeon has images of the organ and tissue surfaces plus the additional information provided by the imaging technology. The individual patient’s anatomy, which is calculated and visualized in 3D based on prior CT and MRI scans, is superimposed on these images.

Maier-Hein plans to test and evaluate the innovative method in computer-assisted endoscopic examinations of the bowel and stomach. Enhancements in these commonly performed surgical procedures would benefit many people, for example in colorectal cancer screening programs.

Lena Maier-Hein, born in 1980, studied computer sciences at the Karlsruhe Institute of Technology (KIT) and at the Imperial College in London and attained her qualification to give lectures (‘Habilitation’) at Heidelberg University in 2013. Since 2009, she has been pursuing research as a post-doc at the DKFZ, where she has been leading an independent junior research group since 2012. Maier-Hein, mother of a daughter since 2012, has already been distinguished with several science awards including the Heinz Maier Leibniz Award of the German Research Foundation (DFG).

The ERC Starting Independent Researcher Grants are awarded by the European Research Council (ERC) and are designed to support excellent young researchers at an early stage of their career when they are starting their own independent research team or program in a European country. Starting Grants comprise EUR 1.5 million for a period of five years. The prestigious research grant is awarded in a highly competitive process in which only one in ten proposals is accepted.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS